BiPAP治疗慢性阻塞性肺疾病并呼吸衰竭的临床分析  

Analysis of BiPAP Treatment in Chronic Obstructive Pulmonary Disease with Respiratory Failure

作　　者：刘晓俊[1] 罗晓勘[2] 杨恂[1] 

机构地区：[1]成都铁路中心医院,四川成都610081 [2]成都市医学信息所,四川成都610091

出　　处：《现代临床医学》2009年第6期423-424,共2页Journal of Modern Clinical Medicine

摘　　要：目的:评价双水平气道正压无创通气(BiPAP)治疗慢性阻塞性肺疾病并呼吸衰竭的临床疗效。方法:将83例确诊为COPD呼吸衰竭患者随机分为两组。对照组,42例,采用常规治疗;治疗组,41例,在常规治疗的基础上同时给予BiPAP治疗。动态观察两组通气前及通气后4 h、24 h的临床表现、生命体征、动脉血气变化。结果:BiPAP治疗4 h后动脉血气明显改善,心率和呼吸频率降低,通气前后各项观察指标与对照组比较均显著好转(P<0.05)。结论:BiPAP对COPD并呼吸衰竭患者的疗效肯定,是一种有效、简便、无创而实用的治疗方法。Objective ：To evaluate the clinical effects of BiPAP ventilation in the treatment of chronic obstructive pulmonary disease （COPD） with respiratory failure. Methods：83 patients confirmed with COPD with respiratory failure were randomly divided into two groups, 42 cases of control group received routine treatment and 41 cases of treatment group received BiPAP treatment under the basis of routine treatment. All groups was observed dynamically on clinical manifestations, vital signs and blood gas changes at 4 hour and 24 hour before and after BiPAP ventilation. Results： Observed indexes including arterial blood gases, heart rate and respiratory rate in treatment group were improved markedly at 4 hours after BiPAP ventilation more than in control group （ P 〈 0.05 ）. Conclusion： BiPAP ventilation in treating COPD with respiratory failure is useful and an effective, simple , harmless and practical method.

关 键 词：双水平气道正压无创通气 慢性阻塞性肺疾病 呼吸衰竭 

分 类 号：R563.8[医药卫生—呼吸系统]